These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cell cycle-dependent antagonistic interactions between paclitaxel and gamma-radiation in combination therapy. Sui M; Dziadyk JM; Zhu X; Fan W Clin Cancer Res; 2004 Jul; 10(14):4848-57. PubMed ID: 15269161 [TBL] [Abstract][Full Text] [Related]
24. [Apoptotic effect of the combined treatment of engineered antibody with paclitaxel on BT474 cells]. Yin HJ; Cheng LS; Duan JL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):260-3. PubMed ID: 17343796 [TBL] [Abstract][Full Text] [Related]
25. In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines. Tanaka R; Ariyama H; Qin B; Takii Y; Baba E; Mitsugi K; Harada M; Nakano S Cancer Chemother Pharmacol; 2005 Jun; 55(6):595-601. PubMed ID: 15731917 [TBL] [Abstract][Full Text] [Related]
26. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines. Tanaka R; Takii Y; Shibata Y; Ariyama H; Qin B; Baba E; Kusaba H; Mitsugi K; Harada M; Nakano S Cancer Chemother Pharmacol; 2005 Sep; 56(3):279-85. PubMed ID: 15875187 [TBL] [Abstract][Full Text] [Related]
27. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169 [TBL] [Abstract][Full Text] [Related]
28. Differential effects of taxol on two human cancer cell lines. Banerjee S; Fallis AG; Brown DL Oncol Res; 1997; 9(5):237-48. PubMed ID: 9306431 [TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention. Au JL; Li D; Gan Y; Gao X; Johnson AL; Johnston J; Millenbaugh NJ; Jang SH; Kuh HJ; Chen CT; Wientjes MG Cancer Res; 1998 May; 58(10):2141-8. PubMed ID: 9605758 [TBL] [Abstract][Full Text] [Related]
30. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines. Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251 [TBL] [Abstract][Full Text] [Related]
31. Anthocyanins induce cell cycle perturbations and apoptosis in different human cell lines. Lazzè MC; Savio M; Pizzala R; Cazzalini O; Perucca P; Scovassi AI; Stivala LA; Bianchi L Carcinogenesis; 2004 Aug; 25(8):1427-33. PubMed ID: 15016660 [TBL] [Abstract][Full Text] [Related]
32. Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9b. Maushagen R; Reers S; Pfannerstill AC; Hahlbrock A; Stauber R; Rahmanzadeh R; Rades D; Pries R; Wollenberg B J Cancer Res Clin Oncol; 2016 Jun; 142(6):1261-71. PubMed ID: 27038158 [TBL] [Abstract][Full Text] [Related]
33. Head and neck cancer cell lines are resistant to mitochondrial-depolarization-induced apoptosis. Zhao M; Mydlarz WK; Zhou S; Califano J ORL J Otorhinolaryngol Relat Spec; 2008; 70(4):257-63. PubMed ID: 18483464 [TBL] [Abstract][Full Text] [Related]
34. Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines. Dietrich CS; Greenberg VL; DeSimone CP; Modesitt SC; van Nagell JR; Craven R; Zimmer SG Gynecol Oncol; 2010 Jan; 116(1):126-30. PubMed ID: 19875160 [TBL] [Abstract][Full Text] [Related]
35. G2/M cell-cycle arrest and apoptosis by n-3 fatty acids in a pancreatic cancer model. Dekoj T; Lee S; Desai S; Trevino J; Babcock TA; Helton WS; Espat NJ J Surg Res; 2007 May; 139(1):106-12. PubMed ID: 17291531 [TBL] [Abstract][Full Text] [Related]
36. Enhanced apoptotic effects of novel paclitaxel analogs on NCI/ADR-RES breast cancer cells. Yang LX; Zhu J; Wang HJ; Holton RA Anticancer Res; 2003; 23(4):3295-301. PubMed ID: 12926066 [TBL] [Abstract][Full Text] [Related]
37. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro. Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891 [TBL] [Abstract][Full Text] [Related]
38. Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in Vitro. Erjala K; Pulkkinen J; Kulmala J; Alanen K; Grenman R Anticancer Res; 2002; 22(6A):3135-42. PubMed ID: 12530056 [TBL] [Abstract][Full Text] [Related]
39. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines. Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R Cancer; 1996 May; 77(9):1940-6. PubMed ID: 8646696 [TBL] [Abstract][Full Text] [Related]
40. Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel. Shang D; Ito N; Kamoto T; Ogawa O Urology; 2007 May; 69(5):1007-12. PubMed ID: 17482960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]